User profiles for Sahar M Hassany

Sahar Hassany

Lecturer of Tropical Medicine and Gastroenterology Departement, Faculty of Medicine …
Verified email at aun.edu.eg
Cited by 1071

[HTML][HTML] Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver …

…, AWN Ndam, EF Moustafa, SM Hassany… - The lancet …, 2017 - thelancet.com
Background Hepatocellular carcinoma is a leading cause of cancer-related death in Africa,
but there is still no comprehensive description of the current status of its epidemiology in …

Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study

…, EF Moustafa, SM Hassany… - Journal of medical …, 2021 - Wiley Online Library
Researchers around the world are working at record speed to find the best ways to treat and
prevent coronavirus disease 2019 (COVID‐19). This study aimed to evaluate the efficacy of …

Predictors of severity and co-infection resistance profile in COVID-19 patients: First report from upper Egypt

…, IM Sayed, A Hosni, SM Hassany… - Infection and drug …, 2020 - Taylor & Francis
Background The emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
resulted in a worldwide devastating effect with a diagnostic challenge. Identifying risk factors …

[HTML][HTML] Do zinc supplements enhance the clinical efficacy of hydroxychloroquine?: a randomized, multicenter trial

…, MSA El Ghafar, M Alboraie, SM Hassany - Biological trace element …, 2021 - Springer
No specific treatment for COVID-19 infection is available up till now, and there is a great urge
for effective treatment to reduce morbidity and mortality during this pandemic. We aimed to …

[HTML][HTML] RETRACTED ARTICLE: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial

…, AF Sherief, M Elgaafary, E Fawzy, SM Hassany… - Scientific reports, 2021 - nature.com
Favipiravir is considered a potential treatment for COVID-19 due its efficacy against different
viral infections. We aimed to explore the safety and efficacy of favipiravir in treatment of …

[HTML][HTML] Fungal infection in patients with end-stage liver disease: low frequency or low index of suspicion

EA Hassan, AS Abd El-Rehim, SM Hassany… - International Journal of …, 2014 - Elsevier
Background End-stage liver disease (ESLD) is associated with dysregulation of the immune
system and increased susceptibility to infections. Although invasive fungal infection (IFI) is a …

Surveillance study of acute neurological manifestations among 439 Egyptian patients with COVID-19 in Assiut and Aswan University Hospitals

…, SM Hassany, A Aly, A Shoyb, M Saber - …, 2021 - karger.com
Background: COVID-19 can be accompanied by acute neurological complications of both
central and peripheral nervous systems (CNS and PNS). In this study, we estimate the …

[HTML][HTML] Prognostic biomarkers in COVID-19 infection: value of anemia, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and D-dimer

…, EF Mostafa, SM Hassany… - The Egyptian Journal of …, 2021 - Springer
Background Being highly infectious disease, COVID-19 exhausts most of efficient healthcare
systems worldwide. Simple and rapid risk stratification methods are mandatory to recognize …

[HTML][HTML] Sero-prevalence of anti-SARS-CoV-2 antibodies among healthcare workers: a multicenter study from Egypt

…, EF Mostafa, SM Bahgat, SM Hassany… - Journal of Infection and …, 2021 - Elsevier
Background Healthcare workers (HCWs) are at a high risk for disease exposure. Given the
limited availability of nucleic acid testing by PCR in low resource settings, serological assays …

Predictors for severity of SARS-CoV-2 infection among healthcare workers

…, AA Abdelmoaty, E Hassan, SM Hassany… - Journal of …, 2021 - Taylor & Francis
Background Healthcare workers (HCWs) are still at higher risk of acquiring severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections than the general population. …